Home › Heart Failure › NCT04196842

Heart Failure Precision Medicine Study

Who can join

Ages 21 and older · All sexes

Inclusion Criteria:

* Diagnosis of Heart failure
* Objective evidence of cardiac abnormality of structure or function (abnormal ECHO) or elevated levels of B-type natriuretic peptide (\>100 pg/ml)
* HF stage B-D and class I-IV

Exclusion Criteria:

* Patients unable to consent
* Inability to comply with the protocol and follow-up requirements
* Patients unable to use a smartphone
* Patients assessed irregularly (less than two visits in one year)
* History of HTx
* Use of Mechanical circulatory support device (MCSD)
* Comorbidities that, according to the PI, have the potential to interfere with the interpretation of the results

About the study

The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.

What is being tested

• Telemonitoring devices (device)

Sponsor: University of California, Davis · Participants: 100 · Started: Oct 16, 2019

Contact the study team

• Erick S Romero, MD · Phone: (916) 703-2071

Official record on ClinicalTrials.gov — NCT04196842

Locations in the U.S.

Conditions

• Heart Failure

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.